A second trial has shown benefit of stopping aspirin 3 months after stenting and continuing solely with ticagrelor monotherapy. The Ticagrelor With or Without Aspirin in Acute Coronary Syndrome After ...

Please provide your email address to receive an email when new articles are posted on . In patients with ACS who had angioplasty and stenting, ticagrelor monotherapy after 1 month reduced bleeding vs.

INDIANAPOLIS and TOKYO, Aug. 26, 2012 /PRNewswire/ -- Daiichi Sankyo Company, Limited (TSE: 4568) and Eli Lilly and Company (NYSE: LLY) today announced data from the TRILOGY ACS study, a phase III ...

ANAHEIM, CA—International, locally adapted programs to improve the care of patients with acute myocardial infarction seem to be showing promise in a variety of settings, according to two new studies.

The Librexia ACS trial was discontinued after an interim analysis showed the study was unlikely to meet its primary endpoint of reducing MACE. The phase 3 Librexia ACS trial evaluating the safety and ...

Munich, Germany – The first trial to study the effect of platelet inhibition in patients with acute coronary syndromes managed medically without revascularisation has found no significant difference ...